Skip to main content

Peer Review reports

From: Cautious addition of targeted therapy to PD-1 inhibitors after initial progression of BRAF mutant metastatic melanoma on checkpoint inhibitor therapy

Original Submission
28 Feb 2021 Submitted Original manuscript
13 Mar 2021 Author responded Author comments - Wolfram Samlowski
Resubmission - Version 2
13 Mar 2021 Submitted Manuscript version 2
20 May 2021 Reviewed Reviewer Report
11 Sep 2021 Reviewed Reviewer Report - Vinicius Vazquez
28 Sep 2021 Author responded Author comments - Wolfram Samlowski
Resubmission - Version 3
28 Sep 2021 Submitted Manuscript version 3
10 Oct 2021 Reviewed Reviewer Report
25 Oct 2021 Reviewed Reviewer Report - Vinicius Vazquez
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
25 Oct 2021 Editorially accepted
7 Nov 2021 Article published 10.1186/s12885-021-08906-1

You can find further information about peer review here.

Back to article page